Peptidomic Identification of Serum Peptides Diagnosing Preeclampsia

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Wen, Qiaojun ^a   Liu, Linda Y ^a   Yang, Ting ^a   Alev, Cantas ^b   Wu, Shuaibin ^a   Stevenson, David K ^a   Sheng, Guojun ^b   Butte, Atul J ^a   Ling, Xuefeng B ^a  

^a STANFORD UNIVERSITY   (United States)

^b RIKEN Center for Biosystems Dynamics Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN; APOLIPOPROTEIN L1; BIOLOGICAL MARKER; FIBRINOGEN; FIBRINOGEN ALPHA; INTER ALPHA TRYPSIN INHIBITOR; INTER ALPHA TRYPSIN INHIBITOR HEAVY CHAIN H4; KININOGEN; KININOGEN I; THYMOSIN BETA4; UNCLASSIFIED DRUG; APOL1 PROTEIN, HUMAN; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN; ITIH4 PROTEIN, HUMAN; KININOGEN 1, HUMAN; LEUKOCYTE ELASTASE INHIBITOR; PEPTIDE FRAGMENT; PLASMA PROTEIN; SERPINA1 PROTEIN, HUMAN; THYMOSIN; THYMOSIN BETA(4);

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; EDEMA; FEMALE; HEADACHE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PEPTIDOMICS; PREDICTIVE VALUE; PREECLAMPSIA; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEINURIA; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; BLOOD; CHEMISTRY; PRE-ECLAMPSIA; PREGNANCY; PROCEDURES; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

ADULT; ALPHA 1-ANTITRYPSIN; APOLIPOPROTEINS; BIOMARKERS; BLOOD PROTEINS; CHROMATOGRAPHY, LIQUID; FEMALE; GLYCOPROTEINS; HUMANS; KININOGENS; LIPOPROTEINS, HDL; PEPTIDE FRAGMENTS; PRE-ECLAMPSIA; PREGNANCY; PROTEINASE INHIBITORY PROTEINS, SECRETORY; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; THYMOSIN; YOUNG ADULT;

EID: 84879197546     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065571     Document Type: Article

References (26)

1. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, et al. (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12: 642-649.
2. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, et al. (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355: 992-1005.
3. Powe CE, Levine RJ, Karumanchi SA, (2011) Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123: 2856-2869.
4. Redman CW, Sargent IL, (2005) Latest advances in understanding preeclampsia. Science 308: 1592-1594.
5. Ling XB, Lau K, Deshpande C, Park JL, Milojevic D, et al. (2010) Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis. Clin Proteomics 6: 175-193.
6. Ling XB, Lau K, Kanegaye JT, Pan Z, Peng S, et al. (2011) A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses. BMC Med 9: 130.
7. Ling XB, Mellins ED, Sylvester KG, Cohen HJ, (2010) Urine peptidomics for clinical biomarker discovery. Advances in clinical chemistry 51: 181-213.
8. Ling XB, Sigdel TK, Lau K, Ying L, Lau I, et al. (2010) Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J Am Soc Nephrol 21: 646-653.
9. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, et al. (2006) Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 116: 271-284.
10. Liotta LA, Petricoin EF, (2006) Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. J Clin Invest 116: 26-30.
11. Snyder SL, Sobocinski PZ, (1975) An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines. Anal Biochem 64: 284-288.
12. Griffin NM, Yu J, Long F, Oh P, Shore S, et al. (2010) Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat Biotechnol 28: 83-89.
13. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
14. Tibshirani R, Hastie T, Narasimhan B, Chu G, (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 99: 6567-6572.
15. Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, et al. (2005) Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 90: 4895-4903.
16. Maynard SE, Min JY, Merchan J, Lim KH, Li J, et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658.
17. Wolf M, Shah A, Lam C, Martinez A, Smirnakis KV, et al. (2005) Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. Am J Obstet Gynecol 193: 16-22.
18. Rajakumar A, Michael HM, Rajakumar PA, Shibata E, Hubel CA, et al. (2005) Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta 26: 563-573.
19. Taylor AP, Rodriguez M, Adams K, Goldenberg DM, Blumenthal RD, (2003) Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence. Int J Cancer 105: 158-164.
20. Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS, (2001) Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 184: 1267-1272.
21. Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ, (1998) Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 179: 1539-1544.
22. Stepan H, Schaarschmidt W, Jank A, Verlohren S, Kratzsch J, (2010) [Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: first experience]. Z Geburtshilfe Neonatol 214: 234-238.
23. Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, et al. (2010) An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 202: 161 e161-161 e111.
24. Esplin MS, Merrell K, Goldenberg R, Lai Y, Iams JD, et al. (2011) Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Am J Obstet Gynecol 204: 391 e391-398.
25. Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, et al. (2009) Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 27: 633-641.
26. Anderson L, Hunter CL, (2006) Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 5: 573-588.